Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist peptide used in diabetes and obesity research. It enhances insulin secretion, suppresses appetite, and improves glycemic control.
Application: Metabolic disease research, obesity and diabetes modeling, preclinical drug candidate evaluation, neuroendocrine function studies
Liraglutide
Liraglutide is a GLP-1 analog used for research in glucose metabolism and appetite regulation. It exhibits prolonged activity due to structural modifications that increase albumin binding.
Application: Metabolic disease research, obesity and diabetes modeling, preclinical drug candidate evaluation, neuroendocrine function studies
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide showing potent effects on glucose regulation and weight reduction. It represents a new class of incretin-based therapeutics under investigation.
Application: Metabolic disease research, obesity and diabetes modeling, preclinical drug candidate evaluation, neuroendocrine function studies
| Sub Product | Details | Size | Price | |
| Semaglutide | View Details | -- | ||
| Liraglutide | View Details | -- | ||
| Tirzepatide | View Details | -- | ||